Probably the saddest thing about our lives is that everything comes to an end. A few days ago, sadly, one of the best things that happened to the internet ended. To be more specific, Maru, the most ...

23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the official launch of an open-source data platform for the Lung Cancer Genetics Study. Launched in 2024, ...

NCCN guidelines are evidence-informed, consensus-driven, and influential in US payer policies, with a focus on multidisciplinary representation and global adaptations. ESMO guidelines reduce care ...

WOODLAND, TEXAS — Fortifi Food Processing Solutions is acquiring Provisur Technologies, a manufacturer of industrial food processing equipment that is based in Chicago. Terms of the acquisition were ...

OXNARD, Calif. -- Dallas Cowboys owner Jerry Jones credited an experimental trial drug for successfully treating advanced melanoma as he disclosed his cancer diagnosis publicly for the first time.

The leisure cruise industry is faring far better than it seems like it should be, and an unlikely Carnival is leading the way. Although Iovance Biotherapeutics shares have never been lower, the ...

The field of pancreatic cancer needs a measurable biological difference — a biomarker — to tell the difference between two subtypes of the disease with a timely and cost-effective clinical test. Fred ...

Community groups are fighting an unusual Louisiana law that restricts how they use data from air-quality monitors, saying it violates free speech. By Hiroko Tabuchi Since 2022, residents of St. James ...

BOSTON — Patients with non-BRCA gene mutations undergoing risk-reduction surgery to prevent tubo-ovarian cancers showed no signs of tubo-ovarian high-grade serous carcinoma or serous tubal ...

In the continuing evolution of personalized medicine, a new study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with ...

PSAT1 and PSRC1 are upregulated in SCLC, with PSRC1 linked to lower survival rates, suggesting potential therapeutic targets. COLEC12, PLLP, and HP are downregulated, affecting immune response and ...